Structure

Physi-Chem Properties

Molecular Weight:  698.28
Volume:  655.447
LogP:  0.338
LogD:  -0.15
LogS:  -3.093
# Rotatable Bonds:  11
TPSA:  244.27
# H-Bond Aceptor:  16
# H-Bond Donor:  7
# Rings:  6
# Heavy Atoms:  16

MedChem Properties

QED Drug-Likeness Score:  0.142
Synthetic Accessibility Score:  6.49
Fsp3:  0.758
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.263
MDCK Permeability:  0.00017458110232837498
Pgp-inhibitor:  0.706
Pgp-substrate:  0.996
Human Intestinal Absorption (HIA):  0.984
20% Bioavailability (F20%):  0.481
30% Bioavailability (F30%):  0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.1
Plasma Protein Binding (PPB):  61.705135345458984%
Volume Distribution (VD):  0.527
Pgp-substrate:  19.341514587402344%

ADMET: Metabolism

CYP1A2-inhibitor:  0.004
CYP1A2-substrate:  0.085
CYP2C19-inhibitor:  0.01
CYP2C19-substrate:  0.095
CYP2C9-inhibitor:  0.002
CYP2C9-substrate:  0.01
CYP2D6-inhibitor:  0.01
CYP2D6-substrate:  0.082
CYP3A4-inhibitor:  0.047
CYP3A4-substrate:  0.08

ADMET: Excretion

Clearance (CL):  1.16
Half-life (T1/2):  0.797

ADMET: Toxicity

hERG Blockers:  0.412
Human Hepatotoxicity (H-HT):  0.184
Drug-inuced Liver Injury (DILI):  0.083
AMES Toxicity:  0.072
Rat Oral Acute Toxicity:  0.119
Maximum Recommended Daily Dose:  0.917
Skin Sensitization:  0.126
Carcinogencity:  0.759
Eye Corrosion:  0.003
Eye Irritation:  0.013
Respiratory Toxicity:  0.95

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC100333

Natural Product ID:  NPC100333
Common Name*:   Borapetoside D
IUPAC Name:   n.a.
Synonyms:   Borapetoside D
Standard InCHIKey:  RDANOZJKKFLLEO-KBAPQYMASA-N
Standard InCHI:  InChI=1S/C33H46O16/c1-32(16-9-21(49-29(16)42)33(2)15(28(41)43-3)5-4-6-20(32)33)10-17(14-7-8-44-12-14)46-31-27(40)25(38)23(36)19(48-31)13-45-30-26(39)24(37)22(35)18(11-34)47-30/h5,7-8,12,16-27,30-31,34-40H,4,6,9-11,13H2,1-3H3/t16-,17+,18+,19+,20-,21-,22+,23+,24-,25-,26+,27+,30+,31+,32+,33-/m0/s1
SMILES:  OC[C@H]1O[C@@H](OC[C@H]2O[C@@H](O[C@@H](c3cocc3)C[C@]3(C)[C@H]4C[C@@H]([C@@]5([C@H]3CCC=C5C(=O)OC)C)OC4=O)[C@@H]([C@H]([C@@H]2O)O)O)[C@@H]([C@H]([C@@H]1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1097582
PubChem CID:   46886851
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0003909] Fatty Acyls
        • [CHEMONTID:0001766] Fatty acyl glycosides
          • [CHEMONTID:0003861] Fatty acyl glycosides of mono- and disaccharides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO26700 Tinospora crispa Species Menispermaceae Eukaryota n.a. n.a. n.a. PMID[20356064]
NPO26700 Tinospora crispa Species Menispermaceae Eukaryota n.a. n.a. n.a. PMID[22283497]
NPO26700 Tinospora crispa Species Menispermaceae Eukaryota leaf Putz City, Chiayi County, Taiwan 2009-Nov PMID[25999202]
NPO26700 Tinospora crispa Species Menispermaceae Eukaryota n.a. n.a. n.a. PMID[28742368]
NPO26700 Tinospora crispa Species Menispermaceae Eukaryota n.a. n.a. n.a. PMID[29397715]
NPO26700 Tinospora crispa Species Menispermaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT306 Cell Line PC-3 Homo sapiens IC50 > 10000.0 nM PMID[468689]
NPT886 Cell Line NIH3T3 Mus musculus IC50 > 10000.0 nM PMID[468689]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC100333 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9742 High Similarity NPC211777
0.9679 High Similarity NPC198047
0.9563 High Similarity NPC160818
0.9563 High Similarity NPC169299
0.95 High Similarity NPC82602
0.949 High Similarity NPC207978
0.9487 High Similarity NPC262872
0.9434 High Similarity NPC97574
0.9434 High Similarity NPC93172
0.929 High Similarity NPC476939
0.929 High Similarity NPC476940
0.9241 High Similarity NPC307383
0.913 High Similarity NPC470182
0.9057 High Similarity NPC472776
0.9057 High Similarity NPC472778
0.9057 High Similarity NPC472777
0.9051 High Similarity NPC44675
0.9051 High Similarity NPC214541
0.9045 High Similarity NPC469503
0.9036 High Similarity NPC262386
0.9032 High Similarity NPC476941
0.9032 High Similarity NPC7388
0.9032 High Similarity NPC476942
0.9012 High Similarity NPC146991
0.9006 High Similarity NPC200782
0.9006 High Similarity NPC69028
0.8968 High Similarity NPC476937
0.8968 High Similarity NPC476938
0.8957 High Similarity NPC472141
0.8957 High Similarity NPC470875
0.8951 High Similarity NPC477405
0.8951 High Similarity NPC472139
0.8938 High Similarity NPC36655
0.8938 High Similarity NPC261597
0.8938 High Similarity NPC45101
0.8931 High Similarity NPC35000
0.8931 High Similarity NPC469336
0.8924 High Similarity NPC147168
0.8896 High Similarity NPC276551
0.8896 High Similarity NPC469849
0.8882 High Similarity NPC475967
0.8868 High Similarity NPC57998
0.8868 High Similarity NPC178932
0.8868 High Similarity NPC282445
0.8868 High Similarity NPC30222
0.8848 High Similarity NPC472652
0.8848 High Similarity NPC271235
0.8846 High Similarity NPC250228
0.8841 High Similarity NPC472670
0.8841 High Similarity NPC307781
0.8834 High Similarity NPC292389
0.8834 High Similarity NPC419
0.8834 High Similarity NPC469338
0.8827 High Similarity NPC477402
0.882 High Similarity NPC299038
0.882 High Similarity NPC187149
0.8812 High Similarity NPC264943
0.8812 High Similarity NPC476262
0.8805 High Similarity NPC476201
0.8797 High Similarity NPC476936
0.8788 High Similarity NPC472282
0.8788 High Similarity NPC472651
0.878 High Similarity NPC470940
0.878 High Similarity NPC271657
0.8773 High Similarity NPC5079
0.8773 High Similarity NPC82851
0.8773 High Similarity NPC149896
0.8765 High Similarity NPC475226
0.8735 High Similarity NPC471397
0.8735 High Similarity NPC472673
0.8734 High Similarity NPC195325
0.872 High Similarity NPC302369
0.872 High Similarity NPC234660
0.872 High Similarity NPC472773
0.872 High Similarity NPC51568
0.872 High Similarity NPC39986
0.872 High Similarity NPC134254
0.8712 High Similarity NPC472653
0.8712 High Similarity NPC335761
0.8704 High Similarity NPC472283
0.8704 High Similarity NPC249021
0.8688 High Similarity NPC44577
0.8679 High Similarity NPC476122
0.8679 High Similarity NPC469335
0.8679 High Similarity NPC159927
0.8675 High Similarity NPC476850
0.8675 High Similarity NPC173516
0.8675 High Similarity NPC476861
0.8667 High Similarity NPC123088
0.8662 High Similarity NPC346
0.8659 High Similarity NPC472771
0.8659 High Similarity NPC18347
0.8659 High Similarity NPC329938
0.8659 High Similarity NPC263432
0.8659 High Similarity NPC117986
0.8659 High Similarity NPC470792
0.8655 High Similarity NPC470938
0.865 High Similarity NPC477403
0.8625 High Similarity NPC18135
0.8623 High Similarity NPC160651
0.8616 High Similarity NPC472654
0.8608 High Similarity NPC470941
0.8606 High Similarity NPC469846
0.8598 High Similarity NPC470789
0.8589 High Similarity NPC197137
0.8589 High Similarity NPC286722
0.8589 High Similarity NPC173544
0.8589 High Similarity NPC472772
0.858 High Similarity NPC141538
0.858 High Similarity NPC296807
0.858 High Similarity NPC281258
0.858 High Similarity NPC155939
0.858 High Similarity NPC469850
0.8563 High Similarity NPC472774
0.8563 High Similarity NPC472775
0.8562 High Similarity NPC196864
0.8562 High Similarity NPC477404
0.8554 High Similarity NPC476857
0.8554 High Similarity NPC476858
0.8554 High Similarity NPC476856
0.8545 High Similarity NPC96443
0.8545 High Similarity NPC290400
0.8537 High Similarity NPC472779
0.8537 High Similarity NPC475295
0.8537 High Similarity NPC473473
0.8537 High Similarity NPC472671
0.8535 High Similarity NPC476944
0.8529 High Similarity NPC94763
0.8528 High Similarity NPC469485
0.8528 High Similarity NPC209364
0.8521 High Similarity NPC159232
0.8519 High Similarity NPC253201
0.8519 High Similarity NPC302054
0.8506 High Similarity NPC242068
0.8506 High Similarity NPC247563
0.8503 High Similarity NPC475779
0.8503 High Similarity NPC214600
0.85 High Similarity NPC125182
0.85 High Similarity NPC69647
0.8494 Intermediate Similarity NPC165218
0.8491 Intermediate Similarity NPC10088
0.8491 Intermediate Similarity NPC221809
0.8488 Intermediate Similarity NPC11062
0.8485 Intermediate Similarity NPC305016
0.8485 Intermediate Similarity NPC25255
0.8481 Intermediate Similarity NPC41182
0.8476 Intermediate Similarity NPC214495
0.8476 Intermediate Similarity NPC475066
0.8476 Intermediate Similarity NPC470118
0.8476 Intermediate Similarity NPC167142
0.8476 Intermediate Similarity NPC470119
0.8471 Intermediate Similarity NPC223415
0.8466 Intermediate Similarity NPC92979
0.8457 Intermediate Similarity NPC472672
0.8457 Intermediate Similarity NPC33938
0.8457 Intermediate Similarity NPC268905
0.8457 Intermediate Similarity NPC75906
0.8452 Intermediate Similarity NPC476853
0.8447 Intermediate Similarity NPC470997
0.8443 Intermediate Similarity NPC472664
0.8434 Intermediate Similarity NPC188649
0.8434 Intermediate Similarity NPC193798
0.8424 Intermediate Similarity NPC474611
0.8421 Intermediate Similarity NPC236004
0.8421 Intermediate Similarity NPC477824
0.8418 Intermediate Similarity NPC137295
0.8418 Intermediate Similarity NPC251865
0.8415 Intermediate Similarity NPC107646
0.8415 Intermediate Similarity NPC126723
0.8412 Intermediate Similarity NPC475641
0.8412 Intermediate Similarity NPC475237
0.8405 Intermediate Similarity NPC237259
0.8405 Intermediate Similarity NPC98206
0.8405 Intermediate Similarity NPC34421
0.8402 Intermediate Similarity NPC472766
0.8402 Intermediate Similarity NPC472765
0.84 Intermediate Similarity NPC105395
0.8395 Intermediate Similarity NPC471000
0.8393 Intermediate Similarity NPC478178
0.8393 Intermediate Similarity NPC23387
0.8385 Intermediate Similarity NPC234494
0.8383 Intermediate Similarity NPC288602
0.8383 Intermediate Similarity NPC476197
0.8383 Intermediate Similarity NPC88841
0.8375 Intermediate Similarity NPC471174
0.8375 Intermediate Similarity NPC255414
0.8373 Intermediate Similarity NPC191828
0.8373 Intermediate Similarity NPC475381
0.8354 Intermediate Similarity NPC470741
0.8353 Intermediate Similarity NPC472659
0.8343 Intermediate Similarity NPC472764
0.8333 Intermediate Similarity NPC476860
0.8333 Intermediate Similarity NPC90953
0.8333 Intermediate Similarity NPC196846
0.8324 Intermediate Similarity NPC478177
0.8324 Intermediate Similarity NPC472665
0.8323 Intermediate Similarity NPC470939
0.8323 Intermediate Similarity NPC310830
0.8323 Intermediate Similarity NPC472767
0.8314 Intermediate Similarity NPC471632

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC100333 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8242 Intermediate Similarity NPD5761 Phase 2
0.8242 Intermediate Similarity NPD5760 Phase 2
0.8136 Intermediate Similarity NPD8434 Phase 2
0.7765 Intermediate Similarity NPD8312 Approved
0.7765 Intermediate Similarity NPD8313 Approved
0.7753 Intermediate Similarity NPD6559 Discontinued
0.7733 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7486 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7473 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7471 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.743 Intermediate Similarity NPD7228 Approved
0.7399 Intermediate Similarity NPD8455 Phase 2
0.7363 Intermediate Similarity NPD7240 Approved
0.7363 Intermediate Similarity NPD6764 Approved
0.7363 Intermediate Similarity NPD6765 Approved
0.7348 Intermediate Similarity NPD7472 Approved
0.7348 Intermediate Similarity NPD7074 Phase 3
0.7333 Intermediate Similarity NPD7799 Discontinued
0.7333 Intermediate Similarity NPD3818 Discontinued
0.7322 Intermediate Similarity NPD7808 Phase 3
0.7305 Intermediate Similarity NPD4628 Phase 3
0.7299 Intermediate Similarity NPD7819 Suspended
0.7297 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7293 Intermediate Similarity NPD7054 Approved
0.7268 Intermediate Similarity NPD7251 Discontinued
0.7264 Intermediate Similarity NPD8404 Phase 2
0.7216 Intermediate Similarity NPD4966 Approved
0.7216 Intermediate Similarity NPD4967 Phase 2
0.7216 Intermediate Similarity NPD4965 Approved
0.7213 Intermediate Similarity NPD6797 Phase 2
0.7204 Intermediate Similarity NPD6784 Approved
0.7204 Intermediate Similarity NPD6785 Approved
0.72 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7175 Intermediate Similarity NPD7075 Discontinued
0.7174 Intermediate Similarity NPD7685 Pre-registration
0.7135 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD6234 Discontinued
0.7095 Intermediate Similarity NPD5494 Approved
0.7069 Intermediate Similarity NPD7458 Discontinued
0.7056 Intermediate Similarity NPD7199 Phase 2
0.7056 Intermediate Similarity NPD8127 Discontinued
0.7053 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.7045 Intermediate Similarity NPD37 Approved
0.7035 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7029 Intermediate Similarity NPD4380 Phase 2
0.7029 Intermediate Similarity NPD6599 Discontinued
0.7022 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7015 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7015 Intermediate Similarity NPD7783 Phase 2
0.7011 Intermediate Similarity NPD5844 Phase 1
0.7005 Intermediate Similarity NPD7435 Discontinued
0.7 Intermediate Similarity NPD8151 Discontinued
0.7 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.6968 Remote Similarity NPD8407 Phase 2
0.6966 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6954 Remote Similarity NPD920 Approved
0.6949 Remote Similarity NPD6801 Discontinued
0.6935 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6919 Remote Similarity NPD7696 Phase 3
0.6919 Remote Similarity NPD7698 Approved
0.6919 Remote Similarity NPD7697 Approved
0.6901 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6898 Remote Similarity NPD8368 Discontinued
0.6897 Remote Similarity NPD6273 Approved
0.6895 Remote Similarity NPD8150 Discontinued
0.6893 Remote Similarity NPD7411 Suspended
0.6889 Remote Similarity NPD3749 Approved
0.6885 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6884 Remote Similarity NPD8320 Phase 1
0.6884 Remote Similarity NPD8319 Approved
0.6881 Remote Similarity NPD7874 Approved
0.6881 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6872 Remote Similarity NPD5402 Approved
0.6866 Remote Similarity NPD7701 Phase 2
0.6865 Remote Similarity NPD3751 Discontinued
0.6853 Remote Similarity NPD6780 Approved
0.6853 Remote Similarity NPD6782 Approved
0.6853 Remote Similarity NPD6777 Approved
0.6853 Remote Similarity NPD6778 Approved
0.6853 Remote Similarity NPD6779 Approved
0.6853 Remote Similarity NPD6776 Approved
0.6853 Remote Similarity NPD6781 Approved
0.6848 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6848 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6848 Remote Similarity NPD6166 Phase 2
0.6839 Remote Similarity NPD642 Clinical (unspecified phase)
0.6839 Remote Similarity NPD2534 Approved
0.6839 Remote Similarity NPD2532 Approved
0.6839 Remote Similarity NPD2533 Approved
0.6834 Remote Similarity NPD7680 Approved
0.6828 Remote Similarity NPD8470 Clinical (unspecified phase)
0.6824 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6816 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6811 Remote Similarity NPD7473 Discontinued
0.68 Remote Similarity NPD7870 Phase 2
0.68 Remote Similarity NPD7871 Phase 2
0.6782 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6782 Remote Similarity NPD6799 Approved
0.678 Remote Similarity NPD3226 Approved
0.678 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6778 Remote Similarity NPD3817 Phase 2
0.6776 Remote Similarity NPD6959 Discontinued
0.6766 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6765 Remote Similarity NPD7801 Approved
0.6761 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6761 Remote Similarity NPD5403 Approved
0.676 Remote Similarity NPD1934 Approved
0.6758 Remote Similarity NPD919 Approved
0.6757 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6751 Remote Similarity NPD7700 Phase 2
0.6751 Remote Similarity NPD7699 Phase 2
0.6748 Remote Similarity NPD7930 Approved
0.6743 Remote Similarity NPD5401 Approved
0.674 Remote Similarity NPD7768 Phase 2
0.6739 Remote Similarity NPD6232 Discontinued
0.6739 Remote Similarity NPD3787 Discontinued
0.6725 Remote Similarity NPD2346 Discontinued
0.6724 Remote Similarity NPD643 Clinical (unspecified phase)
0.6722 Remote Similarity NPD1465 Phase 2
0.6717 Remote Similarity NPD7237 Clinical (unspecified phase)
0.67 Remote Similarity NPD6823 Phase 2
0.6683 Remote Similarity NPD7999 Approved
0.6648 Remote Similarity NPD3882 Suspended
0.6647 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6647 Remote Similarity NPD7097 Phase 1
0.6647 Remote Similarity NPD2800 Approved
0.6646 Remote Similarity NPD1049 Clinical (unspecified phase)
0.6629 Remote Similarity NPD7236 Approved
0.6628 Remote Similarity NPD7266 Discontinued
0.6609 Remote Similarity NPD3750 Approved
0.6609 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6608 Remote Similarity NPD2799 Discontinued
0.6599 Remote Similarity NPD6534 Approved
0.6599 Remote Similarity NPD6535 Approved
0.6596 Remote Similarity NPD7893 Clinical (unspecified phase)
0.6595 Remote Similarity NPD1247 Approved
0.659 Remote Similarity NPD1549 Phase 2
0.659 Remote Similarity NPD970 Clinical (unspecified phase)
0.657 Remote Similarity NPD2796 Approved
0.657 Remote Similarity NPD1551 Phase 2
0.6564 Remote Similarity NPD8360 Approved
0.6564 Remote Similarity NPD8435 Approved
0.6564 Remote Similarity NPD8361 Approved
0.6557 Remote Similarity NPD8155 Clinical (unspecified phase)
0.6557 Remote Similarity NPD7907 Approved
0.6556 Remote Similarity NPD7028 Phase 2
0.6554 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6552 Remote Similarity NPD1243 Approved
0.6552 Remote Similarity NPD6674 Discontinued
0.6545 Remote Similarity NPD7319 Approved
0.6538 Remote Similarity NPD2801 Approved
0.6536 Remote Similarity NPD7239 Suspended
0.6536 Remote Similarity NPD1653 Approved
0.6532 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6532 Remote Similarity NPD1471 Phase 3
0.6532 Remote Similarity NPD6002 Phase 3
0.6532 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6532 Remote Similarity NPD6005 Phase 3
0.6532 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6532 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6532 Remote Similarity NPD6004 Phase 3
0.6529 Remote Similarity NPD6355 Discontinued
0.6529 Remote Similarity NPD1933 Approved
0.6527 Remote Similarity NPD6832 Phase 2
0.6522 Remote Similarity NPD8513 Phase 3
0.6522 Remote Similarity NPD8517 Approved
0.6522 Remote Similarity NPD8515 Approved
0.6522 Remote Similarity NPD8516 Approved
0.6512 Remote Similarity NPD3748 Approved
0.6512 Remote Similarity NPD7033 Discontinued
0.6502 Remote Similarity NPD7497 Discontinued
0.6488 Remote Similarity NPD7583 Approved
0.6488 Remote Similarity NPD7584 Approved
0.6488 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6474 Remote Similarity NPD6099 Approved
0.6474 Remote Similarity NPD2935 Discontinued
0.6474 Remote Similarity NPD6100 Approved
0.6471 Remote Similarity NPD5711 Approved
0.6471 Remote Similarity NPD7229 Phase 3
0.6471 Remote Similarity NPD5710 Approved
0.6465 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6465 Remote Similarity NPD6212 Phase 3
0.6465 Remote Similarity NPD6213 Phase 3
0.6463 Remote Similarity NPD7507 Approved
0.6462 Remote Similarity NPD8424 Clinical (unspecified phase)
0.6462 Remote Similarity NPD4665 Approved
0.6462 Remote Similarity NPD4111 Phase 1
0.6461 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6461 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6456 Remote Similarity NPD7585 Approved
0.6453 Remote Similarity NPD3057 Approved
0.645 Remote Similarity NPD6859 Clinical (unspecified phase)
0.645 Remote Similarity NPD2313 Discontinued
0.6442 Remote Similarity NPD8328 Phase 3
0.6437 Remote Similarity NPD5763 Approved
0.6437 Remote Similarity NPD5762 Approved
0.6437 Remote Similarity NPD2344 Approved
0.6436 Remote Similarity NPD3926 Phase 2
0.6436 Remote Similarity NPD4107 Approved
0.6433 Remote Similarity NPD447 Suspended

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data